Yahoo · Oct 30, 2026
Is Buying McKesson Stock Near Its High A Bad Idea?
For questions about this article or underlying research, email [email protected].

NASDAQ · HSIC
Healthcare · Medical - Distribution
$88.24
Up+$5.74 (+6.96%)
Updated Nov 5, 2026, 2:10 AM
SID Score
5.7/10
Composite research score
Smart Money
58/100
Neutral
Price performance · HSIC
1M range · 21 trading sessions · Daily adjusted prices
Prices through Nov 4, 2026
HSIC closed at $88.24 after 21 trading sessions, up 5.47% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 4, 2026 | $84.12 | $88.48 | $84.06 | $88.24 | 3.9M |
| Nov 3, 2026 | $82.37 | $86.87 | $81.03 | $82.50 | 4.42M |
| Nov 2, 2026 | $85.93 | $87.28 | $85.13 | $86.62 | 2.5M |
| Oct 30, 2026 | $86.57 | $86.945 | $84.49 | $84.88 | 1.2M |
| Oct 29, 2026 | $85.65 | $86.44 | $85.23 | $86.44 | 924.68K |
| Oct 28, 2026 | $84.10 | $85.5726 | $83.97 | $84.96 | 934.46K |
| Oct 27, 2026 | $84.62 | $85.60 | $83.745 | $84.25 | 709.81K |
| Oct 26, 2026 | $85.01 | $85.43 | $84.12 | $84.51 | 937.89K |
| Oct 23, 2026 | $85.50 | $86.05 | $84.43 | $84.96 | 836.78K |
| Oct 22, 2026 | $84.81 | $86.26 | $84.81 | $86.00 | 2.08M |
| Oct 21, 2026 | $84.68 | $85.34 | $83.845 | $85.01 | 1.26M |
| Oct 20, 2026 | $84.55 | $85.635 | $84.23 | $84.68 | 1.23M |
| Oct 19, 2026 | $86.32 | $87.355 | $83.92 | $83.97 | 1.32M |
| Oct 16, 2026 | $87.38 | $88.13 | $85.845 | $86.38 | 1.18M |
| Oct 15, 2026 | $86.78 | $87.33 | $86.24 | $86.99 | 963.23K |
| Oct 14, 2026 | $85.19 | $86.25 | $84.5612 | $85.56 | 1.12M |
| Oct 13, 2026 | $84.76 | $85.32 | $83.87 | $85.03 | 718.38K |
| Oct 12, 2026 | $84.16 | $84.92 | $83.89 | $84.23 | 955.26K |
| Oct 9, 2026 | $84.11 | $85.13 | $83.475 | $84.01 | 1.09M |
| Oct 8, 2026 | $79.95 | $84.66 | $79.37 | $84.63 | 2.68M |
| Oct 7, 2026 | $84.79 | $85.635 | $83.56 | $83.66 | 1.31M |
The latest Smart Investors Daily articles mentioning HSIC.
Company
Market Activity
Research & News
HSIC research
Company profile and research snapshot.
Henry Schein Inc is a solutions company for healthcare professionals powered by a network of people and technology. The company is a provider of healthcare products and services to office-based dental and medical practitioners, as well as alternate sites of care. The company's reportable segments are Global Distribution and Value-Added Services; Global Specialty Products; and Global Technology. It generates the majority of its revenue from the Global Distribution and Value-Added Services segment, which includes distribution to the dental and medical markets of national brand and corporate brand merchandise, as well as equipment and related technical services.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Oct 14, 2026 | Leerink Partners | Market Perform | — |
| Aug 19, 2026 | BTIG | Buy | — |
| Aug 6, 2026 | Barclays | Overweight | — |
| Aug 5, 2026 | Citigroup | Buy | — |
| Aug 5, 2026 | UBS | Neutral | — |
No generated briefing is available yet.
Yahoo · Oct 30, 2026
For questions about this article or underlying research, email [email protected].
Yahoo · Oct 29, 2026
For questions about this article or underlying research, email [email protected].
Yahoo · Oct 29, 2026
Henry Schein (HSIC) heads into its upcoming November 3 earnings release with expectations for slightly lower quarterly earnings per share, even as revenue is projected higher, putting the focus firmly on profit resilience. Recent trading has been muted for Henry Schein, with a 1-day share price return of 0.84% and a year-to-date share price return of 10.6%. The 1-year total shareholder return of 36.33% points to stronger longer term momentum as investors reassess both earnings risk and...
Yahoo · Oct 27, 2026
Henry Schein (HSIC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.


The latest Smart Investors Daily articles mentioning HSIC.